Sanofi SA's Genzyme's Lemtrada approved in Australia for treatment of multiple sclerosis

Thursday, 19 Dec 2013 08:00am EST 

Sanofi SA:Says its Genzyme's Lemtrada (alemtuzumab) has been approved by the Australian Therapeutic Goods Administration (TGA).Says the drug has been approved for the treatment of relapsing forms of multiple sclerosis for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses. 

Company Quote

0.56 +0.74%
5:29am EST